- The move to push their drug into a new demographic shouldn't be surprising to anyone who follows the company's progress, Botox was originally approved for therapeutic uses in 1989 and after wrinkle-smoothing properties were discovered the company worked to have the drug approved for cosmetic purposes, generating $1.42 billion in 2010.
- In a phone interview with Bloomberg Ronny Gal, an analyst with Sanford C. Bernstein & Co noted: "It will grow hair from the existing follicle, and help you maintain the hair you've got," while adding, "It's clear it works in principle, because we know it grows eyebrows and we know it grows lashes."
- Allergan Inc., makers of the plastic surgery drug Botox has entered their eyelash treatment into second clinical stage testing.
- Known as Latisse the product was approved for use in eyelash growth in 2008, generating $82 million last year alone.
- The company expects Latisse to gain upwards of $200 million to $500 million in annual sales by 2020 if tests prove that it can grow hair in patients
- Studies are very weak
- many other options are available for treatment for hair loss
- 212.644.6454
|
|
